Transparency of interests for France
The French law of 29 December 2011 on the strengthening of medicinal and health product safety introduced the concept of transparency in business or other interests, especially between pharmaceutical companies and some other players in the French health sector mentioned in the law.
With this in mind, LFB Group companies* publish below files containing the following data:
- agreements signed with French beneficiaries covered by the law, in 2012 and the first half of 2013,
- benefits of €10 or more granted to French beneficiaries covered by the law, in 2012 and the first half of 2013,
The data published has for the most part been checked, to limit the risk of publishing incomplete or incorrect data. Nevertheless, LFB Group companies cannot guarantee that this data is completely comprehensive, but they undertake to update the files as and when necessary, and to take all appropriate precautions to ensure that any incorrect or incomplete data is deleted or amended.
It should be noted that there may also be discrepancies with any data published in parallel by regulatory organisations because, between transmission to those organisations and publication now, additional inspections and checks have been made and data has been amended or deleted, to comply with the criteria of accuracy and completeness that the LFB Group has set itself.
In accordance with the French data protection act of 6 January 1978, as amended, you have a right to access and correct information regarding yourself (but no right of objection, since there is a statutory obligation to publish your data). You can exercise this right by email to firstname.lastname@example.org or by post to Pôle Transparence, LFB Biomédicaments, 3 avenue des Tropiques, BP 40305 Les Ulis, 91958 COURTABOEUF CEDEX, France; it is best to send your request by post, for reasons of security and confidentiality. Your request should be accompanied by a copy of your national identity card or current passport.
To comply with the provisions on non-reindexation in the above law and decree, and to guarantee the right of correction and the right to be forgotten for people mentioned in the files below, these files are available in image format.
With this in mind, it should also be noted that Article 32 III of the French data protection act stipulates that if a file containing data of a personal nature is reused it must be renotified to the people concerned and that, before it can be used, a further declaration must be made to the French data protection authority by the body intending to reuse it. This means that anyone importing and storing the data in these files is held to be carrying out further processing of personal data.
Data from the 2nd half of 2013 onwards is available from the public website of the French Ministry of Health: https://www.transparence.sante.gouv.fr
*LFB Group companies concerned: Laboratoire français du Fractionnement et des Biotechnologies [LFB SA], LFB Biomédicaments, LFB Biotechnologies, LFB Biomanufacturing and CELLforCURE. These companies have authorised LFB SA to host published data about them on their behalf.